Skip to main
NVO

Novo Nordisk (NVO) Market Capitalization Overview

Market Cap: $198.11B as of Jan 9, 2026

$198.11B
$32.88B (19.90%)past month
As of Jan 9, 2026, Novo Nordisk (NVO) has a market capitalization of $198.11B. Over the past 30 days, its market cap has increased by 8.18%, while in the last 12 months, it has increased by 15.59%.

Market capitalization represents the total value of Novo Nordisk as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Novo Nordisk (NVO) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Novo Nordisk (NVO) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Novo Nordisk (NVO) Market Cap History

DateMarket CapChange
Dec 1, 2025$163.15B-1.31%
Nov 3, 2025$165.32B-17.00%
Oct 1, 2025$199.18B+4.95%
Sep 2, 2025$189.79B+17.00%
Aug 1, 2025$162.22B-30.98%
Jul 1, 2025$235.03B-4.13%
Jun 2, 2025$245.16B+11.09%
May 1, 2025$220.70B-3.57%
Apr 1, 2025$228.87B-23.88%
Mar 3, 2025$300.66B+8.96%
Feb 3, 2025$275.93B-5.56%
Jan 2, 2025$292.18B-19.46%

Novo Nordisk (NVO) End of Year Market Cap History

DateMarket CapChange
2026$198.11B+15.59%
2025$171.40B-40.32%
2024$287.18B-18.01%
2023$350.24B+51.70%
2022$230.88B+18.34%
2021$195.10B

FAQs About Novo Nordisk (NVO) Market Cap

As of Jan 9, 2026, the market capitalization of Novo Nordisk (NVO) is $198.11B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Novo Nordisk’s market capitalization has increased by 19.90%, changing from $165.24B to $198.11B as of Jan 9, 2026.

In the last 3 months, Novo Nordisk’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Novo Nordisk’s market capitalization decreased from $287.18B in January to $171.40B in December, reflecting a -40.32% change.

In the past five years, Novo Nordisk (NVO) has had a compound annual growth rate (CAGR) of -2.56% in market capitalization. This means its market cap has shrunk at an average rate of -2.56% per year.

Novo Nordisk (NVO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.